Literature DB >> 29698122

Clinical Study of Three Dimensional Endoscopic Technique in the Treatment of Thyroid Neoplasm.

Jiasheng Xu1,2, Kaili Liao1, Yuting Luo2.   

Abstract

OBJECTIVE: To evaluate the safety and efficacy of three-dimensional (3D) endoscopic technique in clinical practice.
METHODS: A retrospective analysis of the clinical data of 180 cases of endoscopic thyroid surgery, 88 cases by umbrella 3D endoscopic technique (observation group), 92 cases with common endoscopic technique (control group), comparing two groups of patients with age, surgery related indicators, postoperative complications, recovery condition and others.
RESULTS: There was no significant difference in the average age, tumor diameter, intraoperative bleeding, postoperative drainage, hospitalization time, and pain scores after surgery between the to groups (P > .05); the operation time of the observation group was shorter than the control group [(93.8 + 33.7) minutes versus (135.5 + 37.5) minutes, P < .05]. There was no hoarseness in the observation group, and 2 cases in the control group had transient hoarseness and no permanent hoarseness.
CONCLUSION: The surgical application of 3D endoscopic technique can shorten the time of endoscopic thyroid surgery, reduce the risk of recurrent laryngeal nerve injury, reduce the operation difficulty and operation pressure, greatly reduce the risk of surgical patients, and increase the safety of surgery.

Entities:  

Keywords:  common 2D endoscopic technique; three-dimensional endoscopic technique; thyroidectomy

Mesh:

Year:  2018        PMID: 29698122     DOI: 10.1089/lap.2017.0689

Source DB:  PubMed          Journal:  J Laparoendosc Adv Surg Tech A        ISSN: 1092-6429            Impact factor:   1.878


  1 in total

Review 1.  Comparison between 3-dimensional and 2-dimensional endoscopic thyroidectomy for benign and malignant lesions: a meta-analysis.

Authors:  Zigao Huang; Haiquan Qin; Jiankun Liao; Linghou Meng; Yongjie Qin; Baojia Li; Hao Lai; Xianwei Mo
Journal:  World J Surg Oncol       Date:  2021-01-21       Impact factor: 2.754

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.